Plaintiffs Appeal Ruling Dumping Mirena Cases
Executive Summary
A New York federal court dismissed more than 1,200 claims last month in a class action suit against Bayer due to a lack of evidence. The plaintiffs are now filing an appeal.
You may also be interested in...
Legal News In Brief
Bayer tries to get Mirena complaints thrown out; Medtronic is sued by a patent troll; Supreme Court declines Globus suit; and more.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.